Milestone Pharmaceuticals
MIST
$1.60
Share price
-3.32%
Change (1 day)
-55.80%
Change (1 year)
Categories
Revenue for Milestone Pharmaceuticals (MIST)
Revenue in 2023 (TTM): $1 M
According to Milestone Pharmaceuticals
's latest financial reports the company's current revenue (TTM
) is $1 M.
In 2022 the company made a revenue of $5 M a decrease over the years 2021 revenue that were of $15 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Milestone Pharmaceuticals from 2018 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $1 M | -80% |
| 2022 | $5 M | -66.67% |
| 2021 | $15 M | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |